These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20725776)

  • 1. MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.
    Beeghly-Fadiel A; Lu W; Shu XO; Long J; Cai Q; Xiang Y; Gao YT; Zheng W
    Breast Cancer Res Treat; 2011 Apr; 126(2):507-13. PubMed ID: 20725776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
    PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility.
    Beeghly-Fadiel A; Lu W; Long JR; Shu XO; Zheng Y; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1770-6. PubMed ID: 19454611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.
    Beeghly-Fadiel A; Shu XO; Lu W; Long J; Cai Q; Xiang YB; Zheng Y; Zhao Z; Gu K; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):33-41. PubMed ID: 21119072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinase Gene Polymorphisms Are Associated with Breast Cancer in the Caucasian Women of Russia.
    Pavlova N; Demin S; Churnosov M; Reshetnikov E; Aristova I; Churnosova M; Ponomarenko I
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in inflammation pathway genes and endometrial cancer risk.
    Delahanty RJ; Xiang YB; Spurdle A; Beeghly-Fadiel A; Long J; Thompson D; Tomlinson I; Yu H; Lambrechts D; Dörk T; Goodman MT; Zheng Y; Salvesen HB; Bao PP; Amant F; Beckmann MW; Coenegrachts L; Coosemans A; Dubrowinskaja N; Dunning A; Runnebaum IB; Easton D; Ekici AB; Fasching PA; Halle MK; Hein A; Howarth K; Gorman M; Kaydarova D; Krakstad C; Lose F; Lu L; Lurie G; O'Mara T; Matsuno RK; Pharoah P; Risch H; Corssen M; Trovik J; Turmanov N; Wen W; Lu W; Cai Q; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):216-23. PubMed ID: 23221126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians.
    Ma X; Beeghly-Fadiel A; Lu W; Shi J; Xiang YB; Cai Q; Shen H; Shen CY; Ren Z; Matsuo K; Khoo US; Iwasaki M; Long J; Zhang B; Ji BT; Zheng Y; Wang W; Hu Z; Liu Y; Wu PE; Shieh YL; Wang S; Xie X; Ito H; Kasuga Y; Chan KY; Iwata H; Tsugane S; Gao YT; Shu XO; Moses HL; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1176-84. PubMed ID: 22539603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-association of CYP11A1 polymorphisms and breast cancer among Han Chinese women in Southern China.
    Sun M; Yang X; Ye C; Xu W; Yao G; Chen J; Li M
    Int J Mol Sci; 2012; 13(4):4896-4905. PubMed ID: 22606018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility.
    Sapkota Y; Robson P; Lai R; Cass CE; Mackey JR; Damaraju S
    Eur J Hum Genet; 2012 Jun; 20(6):682-9. PubMed ID: 22258532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP9 Promoter Polymorphism (-1562 C/T) Does not Affect the Serum Levels of Soluble MICB and MICA in Breast Cancer.
    Bargostavan MH; Eslami G; Esfandiari N; Shams Shahemabadi A
    Iran J Immunol; 2016 Mar; 13(1):45-53. PubMed ID: 27026046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.
    Xu X; Wang L; Xu C; Zhang P; Yong F; Liu H; Wang J; Shi Y
    Coron Artery Dis; 2013 Jun; 24(4):259-65. PubMed ID: 23377317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
    Beeghly-Fadiel A; Long JR; Gao YT; Li C; Qu S; Cai Q; Zheng Y; Ruan ZX; Levy SE; Deming SL; Snoddy JR; Shu XO; Lu W; Zheng W
    Cancer Res; 2008 Aug; 68(15):6453-9. PubMed ID: 18648013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in the MMP-7 gene and breast cancer survival.
    Beeghly-Fadiel A; Shu XO; Long J; Li C; Cai Q; Cai H; Gao YT; Zheng W
    Int J Cancer; 2009 Jan; 124(1):208-14. PubMed ID: 18798254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs.
    Guan YP; Yang XX; Yao GY; Qiu F; Chen J; Chen LJ; Ye CS; Li M
    Asian Pac J Cancer Prev; 2014; 15(1):85-91. PubMed ID: 24528085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
    Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
    Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-1 (MMP-1) Promoter polymorphisms are well linked with lower stomach tumor formation in eastern Indian population.
    Dey S; Ghosh N; Saha D; Kesh K; Gupta A; Swarnakar S
    PLoS One; 2014; 9(2):e88040. PubMed ID: 24505369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
    Lei H; Hemminki K; Altieri A; Johansson R; Enquist K; Hallmans G; Lenner P; Försti A
    Breast Cancer Res Treat; 2007 May; 103(1):61-9. PubMed ID: 17033924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York.
    Gaudet MM; Bensen JT; Schroeder J; Olshan AF; Terry MB; Eng SM; Teitelbaum SL; Britton JA; Lehman TA; Neugut AI; Ambrosone CB; Santella RM; Gammon MD
    Breast Cancer Res Treat; 2006 Sep; 99(2):235-40. PubMed ID: 16596327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.